CEBPB and neoplasm: LIP-deficient transgenic mice (CebpbΔuORF) have decreased spontaneous tumor incidence and delayed tumor onset (28–30), whereas mice with elevated LIP (Wap-LIP or Cebpb-/L) have increased tumor development (4, 31).